Lack of persistent effects of ketamine in rodent models of depression (Q46610466)

23 December 2017

title

Lack of persistent effects of ketamine in rodent models of depression (English)

1 reference

23 December 2017

author

Magdalena Sowa-Kućma

3

1 reference

23 December 2017

Gabriel Nowak

object named as

Gabriel Nowak

4

0 references

Piotr Popik

object named as

Piotr Popik

1

0 references

author name string

Tomasz Kos

2

1 reference

23 December 2017

publication date

7 May 2008

1 reference

23 December 2017

published in

Psychopharmacology

1 reference

23 December 2017

volume

198

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

421-430

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-008-1158-z

exact match

0 references

cites work

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-008-1158-Z

Psychedelic and entactogenic drugs in the treatment of depression

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-008-1158-Z

Repeated administration of fluoxetine, desipramine and tranylcypromine increases dopamine D2-like but not D1-like receptor function in the rat

21 January 2018

1 reference

12 December 2020

Enhancement of antidepressant-like effects but not brain-derived neurotrophic factor mRNA expression by the novel N-methyl-D-aspartate receptor antagonist neramexane in mice

1 reference

12 December 2020

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.

1 reference

12 December 2020

Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat.

1 reference

12 December 2020

Down-regulation of cortical beta-adrenoceptors by chronic treatment with functional NMDA antagonists.

1 reference

12 December 2020

NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia

1 reference

12 December 2020

Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain

1 reference

12 December 2020

Antidepressant-like effects of dopamine agonists in an animal model of depression.

1 reference

12 December 2020

Psychiatric applications of bromocriptine therapy

1 reference

12 December 2020

Strain differences in changes in some parameters of cerebral cortical adrenergic system following chronic imipramine administration to rats.

1 reference

12 December 2020

Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression

1 reference

12 December 2020

Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice.

1 reference

12 December 2020

Involvement of NMDA receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice.

1 reference

12 December 2020

Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus

1 reference

12 December 2020

Pharmacological profile of the "triple" monoamine neurotransmitter uptake inhibitor, DOV 102,677.

1 reference

12 December 2020

Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapy

1 reference

12 December 2020

Is the forced swimming test a suitable model for revealing antidepressant activity?

1 reference

12 December 2020

Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjects.

1 reference

12 December 2020

Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach.

1 reference

12 December 2020

Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-D-aspartate receptors and the L-arginine-nitric oxide pathway.

1 reference

12 December 2020

The tail suspension test: a new method for screening antidepressants in mice

1 reference

12 December 2020

Comparison of pramipexole, fluoxetine, and placebo in patients with major depression

1 reference

12 December 2020

Prolonged effect of an anesthetic dose of ketamine on behavioral despair

1 reference

12 December 2020

Two case studies of patients with major depressive disorder given low-dose (subanesthetic) ketamine infusions

1 reference

12 December 2020

Antidepressant effects of ketamine in depressed patients

1 reference

12 December 2020

Depression: a new animal model sensitive to antidepressant treatments

1 reference

12 December 2020

Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment

1 reference

12 December 2020

Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests.

1 reference

12 December 2020

NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine.

1 reference

12 December 2020

The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors

1 reference

12 December 2020

Chronic mild stress-induced anhedonia: a realistic animal model of depression

1 reference

12 December 2020

Pharmacology of Antidepressants

1 reference

12 December 2020

Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.

1 reference

12 December 2020

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

1 reference

12 December 2020

Depression: comfortably numb.

1 reference

12 December 2020

Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice

1 reference

12 December 2020

Behavioral effects of ketamine and toxic interactions with psychostimulants

1 reference

12 December 2020

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

1 reference

12 December 2020

Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants

1 reference

12 December 2020

Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715)

1 reference

12 December 2020

Functional antagonists at the NMDA receptor complex exhibit antidepressant actions

1 reference

12 December 2020

Increased response to ketamine following treatment at long intervals: implications for intermittent use.

1 reference

12 December 2020

Ketamine acts as a non-competitive N-methyl-D-aspartate antagonist on frog spinal cord in vitro.

1 reference

12 December 2020

Antidepressant effect of ketamine during ECT.

1 reference

12 December 2020

Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test

1 reference

12 December 2020

Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine

1 reference

12 December 2020

Repeated intravenous ketamine therapy in a patient with treatment-resistant major depression

1 reference

12 December 2020

10.1007/S00213-008-1158-Z

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

18458881

1 reference

23 December 2017